MPP+-induced cytotoxicity in neuroblastoma cells: Antagonism and reversal by guanosine
Open Access
- 1 September 2007
- journal article
- research article
- Published by Springer Nature in Purinergic Signalling
- Vol. 3 (4) , 399-409
Abstract
Guanosine exerts neuroprotective effects in the central nervous system. Apoptosis, a morphological form of programmed cell death, is implicated in the pathophysiology of Parkinson’s disease (PD). MPP+, a dopaminergic neurotoxin, produces in vivo and in vitro cellular changes characteristic of PD, such as cytotoxicity, resulting in apoptosis. Undifferentiated human SH-SY5Y neuroblastoma cells had been used as an in vitro model of Parkinson’s disease. We investigated if extracellular guanosine affected MPP+-induced cytotoxicity and examined the molecular mechanisms mediating its effects. Exposure of neuroblastoma cells to MPP+ (10 μM–5 mM for 24–72 h) induced DNA fragmentation in a time-dependent manner (p < 0.05). Administration of guanosine (100 μM) before, concomitantly with or, importantly, after the addition of MPP+ abolished MPP+-induced DNA fragmentation. Addition of MPP+ (500 μM) to cells increased caspase-3 activity over 72 h (p < 0.05), and this was abolished by pre- or co-treatment with guanosine. Exposure of cells to pertussis toxin prior to MPP+ eliminated the anti-apoptotic effect of guanosine, indicating that this effect is dependent on a Gi protein-coupled receptor, most likely the putative guanosine receptor. The protection by guanosine was also abolished by the selective inhibitor of the enzyme PI-3-K/Akt/PKB (LY294002), confirming that this pathway plays a decisive role in this effect of guanosine. Neither MPP+ nor guanosine had any significant effect on α-synuclein expression. Thus, guanosine antagonizes and reverses MPP+-induced cytotoxicity of neuroblastoma cells via activation of the cell survival pathway, PI-3-K/Akt/PKB. Our results suggest that guanosine may be an effective pharmacological intervention in PD.Keywords
This publication has 80 references indexed in Scilit:
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- Molecular basis of programmed cell death involved in neurodegenerationTrends in Neurosciences, 2005
- DNA DEGRADATION IN DEVELOPMENT AND PROGRAMMED CELL DEATHAnnual Review of Immunology, 2005
- Mitogen-activated protein kinases in apoptosis regulationOncogene, 2004
- Guanosine protects SH-SY5Y cells against β-amyloid-induced apoptosisNeuroReport, 2004
- Interrupting apoptosis in neurodegenerative disease: potential for effective therapy?Drug Discovery Today, 2004
- Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPKNature Cell Biology, 2003
- Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithiumBrain Research, 2001
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Complexity and Diversity of Mammalian Adenylyl CyclasesAnnual Review of Pharmacology and Toxicology, 1996